Pasithea enters $2.08M ATM equity facility with H.C. Wainwright

Pasithea Therapeutics Corp.

ATM agreement with H.C. Wainwright for up to $2,076,000 in common stock sales.
Sales agent commission: 3% of gross proceeds; company reimburses up to $100k in legal fees.
No minimum obligation; company may suspend or terminate the offering at any time.
Sales will be made on Nasdaq as 'at the market' offerings per Rule 415.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.